Methyltransferase-Glo: A Universal, Bioluminescent and Homogenous Assay for Monitoring all Classes of Methyltransferases

References

• Kundaje A , MeulemanW , ErnstJet al. Integrative analysis of 111 reference human epigenomes: Roadmap Epigenomics Consortium . Nature518 , 317 – 330 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Blancafort P , JinJ , FryeS . Writing and rewriting the epigenetic code for cancer cells: from engineered proteins to small molecules . Mol. Pharm.83 , 563 – 576 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Carr SM La , ThangueNB . Cell cycle control by methylation-phosphorylation switch . Cell Cycle10 , 733 – 734 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Copeland RA . Molecular pathways: protein methyltransferases in cancer . Clin. Cancer Res.19 , 6344 – 6350 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Copeland RA , SolomonME , RichonVM . Protein methyltransferases as a target class for drug discovery . Nat. Rev. Drug Discov.8 , 724 – 732 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Biggar KK , LiSS-C . Non-histone protein methylation as a regulator of cellular signaling and function . Nat. Rev. Mol. Cell Biol.16 , 5 – 17 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bedford MT , ClarksSG . Protein arginine methylation in mammals: who, what, and why . Mol. Cell33 , 1 – 13 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Cheng D , YadavN , KingRW , SwansonMS , WeinsteinEJ , BradfordMT . Small molecule regulators of protein arginine methyltransferases . J. Biol. Chem.279 , 23892 – 23899 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Luo M . Current chemical biology approaches to interrogate protein methyltransferases . ACS Chem. Biol.7 , 443 – 463 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Masaki O , DaphneWB , HaberDA , LiEN . DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development . Cell99 , 247 – 257 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Bestor TH , EdwardsJR , BoulardM . Notes on the role of dynamic DNA methylation in mammalian development . Proc. Natl Acad. Sci. USA112 , 6796 – 6799 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Meyer KD , JaffreyS . The dynamic epitranscriptome: N6-methyladenosine and gene expression control . Nat. Rev Mol. Cell Biol.15 , 313 – 326 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Stunnenberg HG , VermueulenM , AtlasiY . A Me6Age for pluripotency. Methylation of messenger RNA on the adenine base is critical for stem cell commitment and differentiation . Science347 , 614 – 615 ( 2015 ).
   PubMedGoogle Scholar
• Marsala SZ , GioulisM , CeravoloR , TinazziM . A systematic review of catechol-O-methyltransferase inhibitors: efficacy and safety in clinical practice . Clin. Neuropharmacol.35 , 185 – 190 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kiss LE , Soares-da-SilvaP . Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility . J. Med. Chem.57 , 8692 – 8717 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mato JM , CarralesFJ , LuSC , AvilaMA . S-adenosylmethionine: a control switch that regulates liver function . FASEB J.16 , 15 – 26 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Lieber CS , PackerL . S-adenosylmethionine: molecular, biological, and clinical aspects – an introduction . Am. J. Clin. Nutr.76 , 1148S – 1150S ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Fontecave M , AttaM , MulliezE . S-adenosylmethionine: nothing goes to waste . Trends Biochem. Sci.29 , 243 – 249 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lu Q , QuinnAM , PatelMPet al. Perspectives on the discovery of small-molecule modulators for epigenetic processes . J. Biomol. Scr.17 , 555 – 571 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Best JD , CareyN . Epigenetics therapies for non-oncology indications . Drug Dis. Today15 , 1008 – 1014 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Szyf M . Prospects for the development of epigenetic drugs for CNS conditions . Nat. Rev Drug Discov.14 , 461 – 474 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mozzetta C , BoyarchukE , PontisJ , Ait-Si-AliS . Sound of Silence: the properties and functions of repressive Lys methyltransferases . Nat. Rev. Mol. Cell Biol.16 , 499 – 513 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• McGrath J , TrojerP . Targeting histone lysine methylation in cancer . Pharmacol. Ther.150 , 1 – 22 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kaniskan HU , KonzeKD , JinJ . Selective inhibitors of protein methyltransferases . J. Med. Chem.58 , 1596 – 1629 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Horiuchi KY , EasonMM , FerryJJet al. Assay development for histone methyltransferases . Assay Drug Dev. Technol.11 , 227 – 236 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rather P , ChengX , JeltschA . Continuous enzymatic assay for histone methyltransferases . BioTechniques43 , 602 – 608 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wang R , IbáñezG , IslamKet al. Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors . Mol. BioSyst.7 , 2970 – 2981 ( 2011 ).
   PubMedGoogle Scholar
• Klink TA , StaebenM , TwestenKet al. Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay . J. Biomol. Scr.17 , 59 – 70 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Simard JR , PlantM , EmkeyR , YuV . Development and implementation of a high-throughput AlphaLISA assay for identifying inhibitors of EZH2 methyltransferase . Assay Drug Dev. Tech.11 , 152 – 162 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Quinn AM , Allali-HassaniA , VedadiM , SimeonovA . A chemiluminescence-based method for identification histone lysine methyltransferase inhibitors . Mol. BioSyst.6 , 782 – 788 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Drake KM , WatsonVG , KisielewskiA , GlynnR , NapperAD . Sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes . Assay Drug Dev. Technol.12 , 258 – 271 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hemeon I , GutierrezJA , HoM-C , SchrammVL . Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay . Anal. Chem.83 , 4996 – 5004 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ibanez G , McBeanJL , AstudilloYM , LuoM . An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases . Anal. Biochem.401 , 203 – 210 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Maegley KA , KrivacicC , BinghamP , LiuW , BroounA . Comparison of a high-throughput mass spectrometry method and radioactive filter binding to assay the protein methyltransferase PRMT5 . Assay Drug Dev. Technol.13 , 235 – 240 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang JH , ChungTD , OldenburgKR . A simple statistical parameter for use in evaluation and validation of high throughput screening assays . J. Biomol. Screen.4 , 67 – 73 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Anglin JL , SongY . A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L . J. Med. Chem.56 , 8972 – 8983 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• McCabe MT , OrrHM , GanjiGet al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations . Nature492 , 108 – 112 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Knutson AK , WigleTJ , WarholicNMet al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells . Nat. Chem. Biol.8 , 890 – 896 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zheng W , IbanezG , WuHet al. Sinefungin derivatives as inhibitors and structure probes of protein lysine methyltransferase SETD2 . J. Am. Chem. Soc.134 , 18004 – 18014 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Masson P , AdarbesV , BocartS , EstevezS , LoillierB , EspanelX . Hit identification on G9a by AlphaLisa™ technology and hit confirmation using MT-Glo™ . SLAS Abstract ( 2015 ).
   Google Scholar
• Tanega C , ShenM , MottBTet al. Comparison of bioluminescent kinase assays using substrate depletion and product formation . Assay Drug Dev. Technol.7 , 606 – 614 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Auld DS , SouthallNT , JadhavAet al. Characterization of chemical libraries for luciferase inhibitory activity . J. Med. Chem.51 , 2372 – 2386 ( 2008 ).
   PubMed Web of Science ®Google Scholar